HK1063787A1 - Novel ligand for nicotinic acetylcholine receptorsuseful in therapy - Google Patents
Novel ligand for nicotinic acetylcholine receptorsuseful in therapyInfo
- Publication number
- HK1063787A1 HK1063787A1 HK04106588A HK04106588A HK1063787A1 HK 1063787 A1 HK1063787 A1 HK 1063787A1 HK 04106588 A HK04106588 A HK 04106588A HK 04106588 A HK04106588 A HK 04106588A HK 1063787 A1 HK1063787 A1 HK 1063787A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- therapy
- receptorsuseful
- nicotinic acetylcholine
- novel ligand
- ligand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29520601P | 2001-06-01 | 2001-06-01 | |
PCT/SE2002/001031 WO2002096912A1 (en) | 2001-06-01 | 2002-05-29 | Novel ligand for nicotinic acetylcholine receptors useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1063787A1 true HK1063787A1 (en) | 2005-01-14 |
Family
ID=23136711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04106588A HK1063787A1 (en) | 2001-06-01 | 2004-09-01 | Novel ligand for nicotinic acetylcholine receptorsuseful in therapy |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1397366B1 (de) |
JP (1) | JP2004532877A (de) |
KR (1) | KR20040003021A (de) |
CN (1) | CN1294136C (de) |
AT (1) | ATE353332T1 (de) |
BR (1) | BR0210075A (de) |
CA (1) | CA2455341A1 (de) |
DE (1) | DE60218032T2 (de) |
DK (1) | DK1397366T3 (de) |
ES (1) | ES2280538T3 (de) |
HK (1) | HK1063787A1 (de) |
IL (1) | IL158735A0 (de) |
MX (1) | MXPA03010996A (de) |
NO (1) | NO20035333D0 (de) |
NZ (1) | NZ529426A (de) |
PT (1) | PT1397366E (de) |
SI (1) | SI1397366T1 (de) |
WO (1) | WO2002096912A1 (de) |
ZA (1) | ZA200308779B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
BR0309342A (pt) * | 2002-04-18 | 2005-02-15 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas |
BR0309343A (pt) * | 2002-04-18 | 2005-02-15 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas |
MXPA04010190A (es) * | 2002-04-18 | 2005-02-03 | Astrazeneca Ab | Compuestos heterociclicos. |
KR20060094962A (ko) | 2003-10-21 | 2006-08-30 | 아스트라제네카 아베 | 스피로푸로피리딘 아릴 유도체 |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
MY157518A (en) | 2008-06-20 | 2016-06-15 | Astrazeneca Ab | Dibenzothiazepine derivatives and use thereof |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
RS54742B1 (sr) | 2010-05-17 | 2016-10-31 | Forum Pharmaceuticals Inc | Kristalni oblik (r)-7-hlor-n-(hinuklidin-3-il)benzo[b]tiofen-2-karboksamid hidrohlorid monohidrata |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
WO2013169646A1 (en) | 2012-05-08 | 2013-11-14 | Envivo Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
ES2694299T3 (es) | 2013-02-07 | 2018-12-19 | Heptares Therapeutics Limited | Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4 |
WO2014202999A1 (en) | 2013-06-21 | 2014-12-24 | Takeda Cambridge Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ500643A (en) * | 1997-05-30 | 2001-12-21 | Neurosearch As | Spiro-quinuclidine derivatives and their use in treating conditions responsive to nicotinic ACh receptor modulators |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
-
2002
- 2002-05-29 IL IL15873502A patent/IL158735A0/xx unknown
- 2002-05-29 NZ NZ529426A patent/NZ529426A/en unknown
- 2002-05-29 CN CNB028110498A patent/CN1294136C/zh not_active Expired - Fee Related
- 2002-05-29 DE DE60218032T patent/DE60218032T2/de not_active Expired - Fee Related
- 2002-05-29 WO PCT/SE2002/001031 patent/WO2002096912A1/en active IP Right Grant
- 2002-05-29 CA CA002455341A patent/CA2455341A1/en not_active Abandoned
- 2002-05-29 DK DK02731063T patent/DK1397366T3/da active
- 2002-05-29 PT PT02731063T patent/PT1397366E/pt unknown
- 2002-05-29 AT AT02731063T patent/ATE353332T1/de not_active IP Right Cessation
- 2002-05-29 SI SI200230510T patent/SI1397366T1/sl unknown
- 2002-05-29 KR KR10-2003-7015462A patent/KR20040003021A/ko not_active Application Discontinuation
- 2002-05-29 MX MXPA03010996A patent/MXPA03010996A/es active IP Right Grant
- 2002-05-29 ES ES02731063T patent/ES2280538T3/es not_active Expired - Lifetime
- 2002-05-29 EP EP02731063A patent/EP1397366B1/de not_active Expired - Lifetime
- 2002-05-29 JP JP2003500091A patent/JP2004532877A/ja active Pending
- 2002-05-29 BR BR0210075-4A patent/BR0210075A/pt not_active IP Right Cessation
-
2003
- 2003-11-11 ZA ZA200308779A patent/ZA200308779B/en unknown
- 2003-11-28 NO NO20035333A patent/NO20035333D0/no unknown
-
2004
- 2004-09-01 HK HK04106588A patent/HK1063787A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2280538T3 (es) | 2007-09-16 |
SI1397366T1 (sl) | 2007-06-30 |
WO2002096912A1 (en) | 2002-12-05 |
EP1397366A1 (de) | 2004-03-17 |
ZA200308779B (en) | 2005-02-11 |
MXPA03010996A (es) | 2004-02-27 |
NZ529426A (en) | 2005-07-29 |
DK1397366T3 (da) | 2007-05-07 |
NO20035333D0 (no) | 2003-11-28 |
DE60218032D1 (de) | 2007-03-22 |
DE60218032T2 (de) | 2007-08-16 |
BR0210075A (pt) | 2004-08-17 |
CN1512995A (zh) | 2004-07-14 |
IL158735A0 (en) | 2004-05-12 |
PT1397366E (pt) | 2007-04-30 |
JP2004532877A (ja) | 2004-10-28 |
CN1294136C (zh) | 2007-01-10 |
ATE353332T1 (de) | 2007-02-15 |
KR20040003021A (ko) | 2004-01-07 |
CA2455341A1 (en) | 2002-12-05 |
EP1397366B1 (de) | 2007-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1063787A1 (en) | Novel ligand for nicotinic acetylcholine receptorsuseful in therapy | |
MXPA03006093A (es) | Derivados de n(fenilsulfonil)glicina y su uso terapeutico. | |
MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
DE60112974D1 (en) | Carbolinderivate | |
CY1113054T1 (el) | Παραγωγα διαμινης | |
HK1080470A1 (en) | Heterocyclic compounds | |
YU6303A (sh) | Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa | |
HK1079522A1 (en) | Thienyl compounds | |
ZA200204667B (en) | Hybrid slot machine. | |
GB0128996D0 (en) | Organic compounds | |
ZA200608416B (en) | Herbicidal composition | |
UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
DE60216233D1 (en) | Carbolinderivate | |
TW200519111A (en) | N3-substituted imidazopyridine C-KIT inhibitors | |
MXPA02012076A (es) | Compuestos quimicos. | |
MXPA03002911A (es) | Compuestos quimicos. | |
AU2001266575A1 (en) | Chemical compounds | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
BR0103824A (pt) | Vernizes em pó de pur foscos | |
GB0018951D0 (en) | Novel compounds | |
WO2002036557A3 (en) | Fluoroborate salts comprising a reactive cation and uses thereof | |
GB0027705D0 (en) | Novel compounds | |
MXPA05003315A (es) | Un sistema de liberacion controlada que contiene temozolomida. | |
MXPA06000372A (es) | Compuestos de silicio y su uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110529 |